Please provide your email address to receive an email when new articles are posted on . Private and professional driving restrictions after ICD implantation may negatively impact patient daily living ...
Please provide your email address to receive an email when new articles are posted on . Patients with HF and CAD who increased their daily levels of physical activity after receiving an implantable ...
Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...
Small increases in daily physical activity are associated with a boost in 1-year survival in patients with heart failure and coronary disease who received an implantable cardioverter defibrillator ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System ...
Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...
In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...
Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback